Clovis Oncology Obtains $130,000,000 New Financing Round

  • Feed Type
  • Date
    11/15/2011
  • Company Name
    Clovis Oncology
  • Mailing Address
    2525 28th Street Boulder, CO 80301
  • Company Description
    Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
  • Website
    http://www.Clovisoncology.com
  • Transaction Type
    IPO
  • Transaction Amount
    $130,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy